Literature DB >> 31963874

Altertoxins with Quorum Sensing Inhibitory Activities from The Marine-Derived Fungus Cladosporium sp. KFD33.

Fei Zhang1,2, Liman Zhou1, Fandong Kong1, Qingyun Ma1, Qingyi Xie1, Jiuhui Li1, Haofu Dai1, Lei Guo2, Youxing Zhao1.   

Abstract

Five new perylenequinone derivatives, altertoxins VIII-XII (1-5), as well as one known compound cladosporol I (6), were isolated from the fermentation broth of the marine-derived fungus Cladosporium sp. KFD33 from a blood cockle from Haikou Bay, China. Their structures were determined based on spectroscopic methods and ECD spectra analysis along with quantum ECD calculations. Compounds 1-6 exhibited quorum sensing inhibitory activities against Chromobacterium violaceum CV026 with MIC values of 30, 30, 20, 30, 20 and 30 μg/well, respectively.

Entities:  

Keywords:  Cladosporium sp.; altertoxins; quorum sensing inhibitory activity

Year:  2020        PMID: 31963874      PMCID: PMC7024320          DOI: 10.3390/md18010067

Source DB:  PubMed          Journal:  Mar Drugs        ISSN: 1660-3397            Impact factor:   5.118


1. Introduction

The unremitting discovery of antibiotics showed a promising prospect for the bacterial infections, but also resulted in the serious resistance of antibiotics. Bacteria have evolved a variety of resistance mechanisms [1,2]. Quorum sensing (QS) is the regulation of gene expression in response to fluctuations in cell-population density among diverse bacterial species [3]. QS controls the production of virulence factors in bacteria in a population density dependent manner through intercellular communication mechanism [3]. QS inhibitors (QSIs) can inhibit the QS mechanism and attenuate virulence without influencing bacterial growth. Thus, QSIs can be used to disarm pathogens in the host and are not easy to cause bacterial resistance compared to conventional antibiotics [4,5]. The search for efficient QSIs is supposed to be an effective method to solve problems of bacterial infection and antibiotic resistance. Based on this, a screening system has been established for searching of QSIs [6]. Due to the special environmental conditions, marine-derived fungi, as a rich source of various compounds with complex structures and excellent activities, have attracted more and more attentions [7]. Our previous research on new bioactive metabolites from the marine-derived fungi has led to the isolation and identification of many new QSIs, such as aculene E and penicitor B, aculene C, aculene D, aspergillumarins A–B [8], asperochrin D, asperochrin F, (3R,4R)-4,7-dihydroxymellein, asperochrin A, and asteltoxin [9]. As our ongoing research, the fungus Cladosporium sp. KFD33 was isolated from a blood cockle from Haikou Bay, China. The EtOAc extract of the fermentation broth of this fungus showed obvious QS inhibitory activity against Chromobacterium violaceum CV026. Subsequent chemical investigation on the EtOAc extract of the fermentation broth had led to the isolation of five new compounds, named altertoxins VIII–XII (1–5), as well as a known one, cladosporol I (6) [10] (Figure 1). All of the new compounds showed obvious QS inhibitory activities. Herein, the isolation, structure elucidation, and QS inhibitory activity of compounds 1–6 are described.
Figure 1

The chemical structures of compounds 1–6.

2. Results and Discussions

Compound 1 was obtained as a dark yellow powder, and its molecular formula was determined as C20H16O3 on the basis of HRESIMS data, indicating 13 degrees of unsaturation. The 13C NMR and HSQC spectra showed 20 carbon signals assigned to four methylenes, 14 aromatic carbons with five protonated, one oxygenated sp3 methine, and a conjugated ketone carbonyl. Analysis of its 1H and 13C NMR data (Table 1 and Table 2) revealed the presence of a 1,2,3-trisubstituted and a 1,2,3,4-tetrasubstituted benzene rings. The COSY correlations (Figure 2) of H2-3/H2-2 and H-6/H-7 along with the HMBC correlations from H2-3 (δH 2.84) to C-4 (δC 204.8), C-4a (δC 110.7), C-1(δC 125.2) and C-2 (δC 23.6), from H2-2 (δH 3.22) to C-8a (δC 131.0) and C-1, from H-6 (δH 7.13) to C-8 (δC 121.3) and C-4a, and from H-7 (δH 8.92) to C-5 (δC 161.8) and C-8a, suggested the presence of a substituted 1-tetralone moiety. The observed COSY correlations of H-1′/H2-2′/H2-3′ as well as the HMBC correlations from H-1′ (δH 4.80) to C-8′a (δC 139.7) and C-4′a (δC 126.1), from H2-3′ (δH 2.96, 3.15) to C-4′ (δC 132.9), from H2-2′ (δH 1.84, 2.06) to C-4′, from H-6′ (δH 8.52) to C-8′ (δC 123.8) and C-4′a, and from H-7′ (δH 7.52) to C-5′ (δC 128.7) and C-4′a revealed the presence of a substituted 1-butanol moiety. Furthermore, the observed HMBC correlations from H2-2 to C-4′ and from H-3′ to C-1 suggested that there is a C-1/C-4′ linkage. The observed HMBC correlations from H-7 to C-5′ and from H-6′ to C-8 suggested that there is a C-8/C-5′ linkage. The above data revealed that compound 1 was structurally similar to altertoxin VII [11], except for the absence of a hydroxyl group located at C-7′. The ECD curve of 1 showed negative Cotton effects (CEs) around 225 and 260 nm and positive one around 280 nm, which is very similar to that of altertoxin VII [11], suggesting their same absolute configuration, i.e., 1′R.
Table 1

1H (500 MHz) data of 1–5 in DMSO.

Position12/345
δH (J in Hz)δH (J in Hz)δH (J in Hz)δH (J in Hz)
1 4.81, dd, (3.2, 3.2)
23.22, t, (7.4)2.84, t, (6.0)2.92, overlap2.01, m
2.05, m
32.84, t, (7.4)1.80, overlap1.81, m2.36, overlap
1.92, overlap2.97, ddd, (18.4, 13.2, 5.9)
4 2.78, overlap2.78, m
2.86, overlap2.90, overlap
67.13, d, (9.1)7.04, d, (9.0)7.11, d, (9.0)6.76, d, (8.8)
78.92, d, (9.1)8.32, d, (9.0)8.40, d, (9.0)7.31, d, (8.8)
1′4.80, dd, (3.6, 8.4)4.74, dd, (8.3, 3.7)4.47, m6.73, overlap
2′1.84, dtd, (13.0, 8.7, 4.7)1.78, overlap1.97, overlap5.89, overlap
2.06, m2.00, m2.15, m
3′2.96, ddd, (16.7, 9.0, 4.8)2.82, overlap2.89, overlap2.29, ddd, (16.9, 6.3, 6.3)
3.15, ddd, (16.7, 7.0, 4.8)3.02, m3.03, m2.47, m
4′ 4.34, dd, (12.6, 7.0)
5′ 5.89, overlap
6′8.52, d, (8.3)8.39, d, (8.3)8.53, d, (8.4)6.74, overlap
7′7.52, dd, (7.1, 8.3)7.37, dd (7.1, 8.3)7.43, dd, (7.0, 8.4)6.55, d, (8.0)
8′7.58, d, (7.1)7.45, d, (7.1)7.39, d, (7.0)
9′ 3.24, s
5-OH13.15, s 9.52, s12.57, s
1′-OH5.40, s5.26, s 9.39, s
Table 2

13C NMR (125 MHz) data of 1–5 in DMSO.

Position12/345
1125.2, C128.7, C129.3, C61.3, CH
223.6, CH227.1, CH227.0, CH229.8, CH2
336.3, CH221.9, CH221.8, CH232.1, CH2
4204.8, C23.4, CH223.3, CH2206.3, C
4a110.7, C119.0, C118.9, C115.1, C
5161.8, C152.1, C152.2, C160.5, C
6117.0, CH115.5, CH115.5, CH117.2, CH
7133.4, CH121.5, CH121.5, CH137.3, CH
8121.3, C122.2, C122.1, C132.9, C
8a131.0, C129.7, C129.6, C142.7, C
1′67.2, CH67.6, CH76.8, CH121.9, CH
2′31.2, CH231.5, CH227.2, CH2125.9, CH
3′24.0, CH223.8, CH222.5, CH230.3, CH2
4′132.9, C127.9, C127.5, C37.5, CH
4′a126.1, C125.9, C126.0, C139.4, C
5′128.7, C129.3, C129.6, C117.9, CH
6′121.4, CH121.2, CH122.2, CH127.7, CH
7′126.2, CH125.1, CH124.6, CH113.7, CH
8′123.8, CH123.1, CH125.2, CH152.6, C
8′a139.7, C139.2, C134.1, C121.2, C
9′ 55.2, CH3
Figure 2

Key COSY and HMBC correlations of compounds 1–5.

Compounds 2 and 3 were obtained as yellow powder, exhibiting two totally overlapped peaks over Rp-18 column and two independent peaks with a peak area ratio of 1:2 over a chiral column (Supporting information), suggesting that they are pair of enantiomers, which were different to each other at the absolute configuration in C-1′. Their formulas were determined as C20H18O2 on the basis of HRESIMS, indicating 12 degrees of unsaturation. Analysis of the 1D NMR data of 2 and 3 revealed that their planar structures are similar to that of 1, except that the C-4 carbonyl in 1 was replaced by a methylene in 2 and 3. This deduction was further confirmed by COSY correlations of H2-2/H2-3/H2-4. In order to determine the absolute configuration of the stereocenter C-1′ of compounds 2 and 3, the ECD spectra of (R)-2 and (S)-2 were calculated and compared with the experimental ECD spectra of 2 and 3. As can be seen in Figure 3, the calculated ECD spectra for (R)-2 and (S)-2 matched well with the experimental ECD spectra of 2 and 3, respectively, indicating that the absolute configuration of C-1′ in compound 2 is R and in compound 3 is S.
Figure 3

Experimental ECD spectra for compounds 1–6 and calculated ECD spectra for (R)-2 and (S)-2.

The molecular formula of compound 4 was determined as C21H20O2 based on HRESIMS, indicating 12 degrees of unsaturation. The 13C NMR data of 4 are similar to those of 2 and 3 except for the presence of a methoxy carbonC 55.2) in 4. In the HMBC spectrum, correlation from the protons of this carbon to C-1′ (δC 76.8) was observed, indicating that the OH-1′ in 2 or 3 was methylated in 4. The remaining substructure of 4 was determined to be the same as those of 2 and 3 by detailed analysis of its 2D NMR data (Figure 2). The absolute configuration of the stereocenter C-1′ in 4 was determined to be the same as that of 2 by their similar ECD curves (Figure 3) and same sign of optical rotation values. Compound 5 was obtained as yellow powder, and its formula was determined as C20H18O4 on the basis of HRESIMS data, indicating 12 degrees of unsaturation. Comprehensive analysis of the NMR data of 5 revealed that its structure is very similar to that of cladosporol I (6), except for the absence of the C-1′ carbonyl and the presence of a double bond which was located at C-1′ (δC 121.9) and C-2′ (δC 125.9) in 5, as deduced from the COSY correlations of H-1′/H-2′/H-3′/H-4′ as well as the HMBC correlations from H2-3′ (δH 2.29, 2.47) to C-1′ and C-4′a (δC 139.4) and from H-2′ (δH 5.89) to C-4′ (δC 37.5) and C-8′a (δC 121.2). The absolute stereochemistry of the asymmetric C-4′ was estimated from the ECD spectrum. In the ECD spectrum of 5, there was a strong splitting cotton effect centered at 216 nm, which should be originated from exciton chirality caused by interaction between two phenolic chromophores [12]. Thus, according to the exciton chirality rule, the absolute stereochemistry of C-4′ was determined to be S. In addition, the absolute configuration of the C-1 stereocenter in cladosporol I (6) has been determined by comparison of the experimental ECD curve with the calculated ECD curves of the two C-1 epimers (1R,4S)-6 and (1S,4S)-6 [8]. According the results, the calculated ECD curve for (1S,4S)-6 showed an intense positive CE around 225 nm, which matched well with the experimental one and was absent in the calculated ECD curve for (1R,4S)-6. Thus, the intense positive CE around 225 nm can be used to differentiate (1R,4S)-6 and (1S,4S)-6. The experimental ECD curve of 5, with an intense positive CE around 225 nm, is very similar to that of (1S,4S)-6, indicating that the absolute configuration of C-1 is S, same as that of 6. All the isolated compounds were tested for QS inhibitory activity against Chromobacterium violaceum CV026 [6]. Compounds 1–6 showed obvious activities (Figure S34, Supporting Information) and the minimum inhibitory concentration (MIC) values were finally determined to be 30, 30, 20, 30, 20 and 30 μg/well, respectively.

3. Experimental

3.1. General Experimental Procedures

The NMR spectra were recorded with a Bruker AV-500 spectrometer (Bruker, Bremen, Germany) using TMS as an internal standard. The mass spectrometric (HRESIMS) data were acquired using an API QSTAR Pulsar mass spectrometer (Bruker, Bremen, Germany). Optical rotations were measured with a JASCO P-1020 digital polarimeter (Anton Paar, Graz, Austria). The infrared spectra were recorded on a Shimadzu UV2550 spectrophotometer (Shimadzu, Kyoto, Japan). Silica gel (60–80 and 200–300 mesh; Qingdao Haiyang Chemincal Co. Ltd., Qingdao, China) and Rp-C18 (20–45 µm; Fuji Silysia Chemical Ltd., Durham, NC, USA) were used for column chromatography. Semipreparative high-performance liquid chromatography (HPLC) equipped with octadecyl silane (ODS) column (Cosmosil ODS-A, 10 × 250 nm, 5 µm, 4 mL/min) and chiral column (CHIRALPAK IC, 4.6 × 250 nm, 5 µm, 1 mL/min) were used for purification of compounds. The solvents used for the purification of compounds, such as ethyl acetate, methanol, chloroform and methanol, were of analytical pure (Concord Technology Co. Ltd., Tianjin, China).

3.2. Fungus Material

The fungal strain Cladosporium sp. KFD33 with yellow mycelium was isolated from a blood cockle in the Haikou Bay, Hainan province, in China in August 2018. After grinding, the sample (1 g) was diluted to 10−2 g/mL with sterile H2O, 100 μL of which was spread on a PDA medium plate containing chloramphenicol as bacterial inhibitor. It was identified by its morphological characteristics and 18S rRNA gene sequences (GenBank accessing No. MN737504, Supporting Information), the used primers of which were NS1 (GTAGTCATATGCTTGTCTC) and NS6 (GCATCACAGACCTGTTATTGCCTC). A reference culture of Cladosporium sp. KFD33 is deposited in our laboratory and which maintained at −80 °C.

3.3. Culture Conditions

Plugs of agar, supporting mycelial growth, were cut from solid culture medium and transferred aseptically to a 1000 mL Erlenmeyer flask, containing 300 mL liquid medium (peptone 5 g/L, yeast extract 2 g/L, glucose 20 g/L, MgSO4 0.5 g/L, KH2PO4 2 g/L, pH 6.5). The fungus was cultured under static conditions at room temperature for 30 days on the shelf of our laboratory.

3.4. Extraction and Isolation

The whole culture broth (20 L) was harvested and filtered to yield the mycelium cake and liquid broth. The mycelium cake and liquid broth were extracted by EtOAc for three times, respectively. The EtOAc solution was evaporated under reduced pressure. A total of 10 g EtOAc extract was obtained. The EtOAc extract was submitted to silica gel vacuum liquid chromatography using step gradient elution with PE/EtOAc (8:1, 6:1, 4:1, 2:1, 1:1, 0:1, v/v) to obtain six fractions (Frs.1–6) based on HPLC analysis. Fr.1 (2 g) was further chromatographed on Rp-C18 silica gel column eluted with MeOH/H2O (from 10%–100%) to give three subfractions (Fr.1-1–Fr.1-3). Compound 1 (1.0 mg, tR 25.9 min), 5 (1.1 mg, tR 10.0 min), and 6 (5.3 mg, tR 19.6 min) were obtained from Fr.1-1 (15.0 mg) by ODS chromatography eluting with MeOH-H2O (10%–100%) and semipreparative HPLC (40% MeOH/H2O, containing 0.1% Formic acid, 4.0 mL·min−1). The mixture of compounds 2 and 3 (2.1 mg, tR 10.7 min) and 4 (1.9 mg, tR 32.2 min) were obtained from Fr.1-2 (6.3 mg) by ODS chromatography eluting with MeOH/H2O (10%–100%) and semipreparative HPLC (65% MeOH/H2O, containing 0.1% Formic acid, 4.0 mL·min−1). Compounds 2 (0.3 mg, tR 24.6 min) and 3 (0.5 mg, tR 27.2 min) were further obtained from their mixture by semipreparative HPLC (99% Hexane/EtOH, 1.0 mL·min−1), using a chiral column. Altertoxin VIII (1): Dark yellow powder; −9.0 (c 0.1, MeOH); UV (CH3OH) λmax (logε): 252 (3.16) nm; 217 (2.97); ECD (CH3OH) λmax (∆ε): 222 (−1.94) nm; 237 (−0.32) nm; 250 (−0.71) nm; 270 (0.05) nm; 322 (−0.10) nm; IR(KBr) νmax: 3418, 2924, 2856, 1625, 1415, 1027 cm−1; 1H and 13C NMR spectral data, Table 1 and Table 2; HRESIMS m/z 327.0985 ([M + Na]+ calcd 327.0992). Altertoxin IX (2): Yellow powder; +35.0 (c 0.01, MeOH); UV (CH3OH) λmax (logε): 264 (3.14) nm; ECD (CH3OH) λmax (∆ε): 226 (16.08) nm; 261 (1.77) nm; 278 (−0.39) nm; 312 (2.16) nm; IR(KBr) νmax: 3437, 2925, 1569, 1415 cm−1; 1H and 13C NMR spectral data, Table 1 and Table 2; HRESIMS m/z 313.1186 ([M + Na]+ calcd 313.1199). Altertoxin X (3): Yellow powder; −34.0 (c 0.01, MeOH); UV (CH3OH) λmax (logε): 264 (3.14) nm; ECD (CH3OH) λmax (∆ε): 225 (−9.23) nm; 250 (1.18) nm; 265 (1.56) nm; 276 (−0.41) nm; 312 (−0.41) nm; 324 (0.34) nm; IR(KBr) νmax: 3437, 2925, 1569, 1415 cm−1; 1H and 13C NMR spectral data, Table 1 and Table 2; HRESIMS m/z 313.1186 ([M + Na]+ calcd 313.1199). Altertoxin XI (4): Yellow powder; +18.0 (c 0.01, MeOH); UV (CH3OH) λmax (logε): 264 (3.16) nm; ECD (CH3OH) λmax (∆ε): 226 (3.44) nm; 238 (−0.05) nm; 267 (0.48) nm; 284 (0.06) nm; 314 (0.34) nm; 336 (−0.09) nm; IR (KBr) νmax: 3440, 2924, 2854, 1689, 1584, 1418, 1207 cm−1; 1H and 13C NMR spectral data, Table 1 and Table 2; HRESIMS m/z 327.1342 ([M + Na]+ calcd 327.1356). Altertoxin XII (5): Yellow powder; +61.0 (c 0.01, MeOH); UV (CH3OH) λmax (logε): 261 (3.21) nm; ECD (CH3OH) λmax (∆ε): 207 (−4.32) nm; 223 (13.32) nm; 237 (2.71) nm; 256 (6.19) nm; 272 (0.18) nm; 287 (1.80) nm; 346 (−1.24) nm; IR (KBr) νmax: 3442, 2923, 2851, 1636, 1453, 1355, 1235, 807 cm−1; 1H and 13C NMR spectral data, Table 1 and Table 2; HRESIMS m/z 361.0856 ([M + K]+ calcd 361.0837).

3.5. QS Inhibitory Assays of C. Violaceum CV026

An overnight culture of C. violaceum CV026 [9] in LB broth (OD600 ≈ 1.0) was prepared. Then 15 mL LB agar plate were flooded with 1 mL of this culture and C6-HSL at concentration of 500 nM to prepare an agar plate as a lawn. 5-mm diameter wells were bored in the agar plate using a flame-sterilized glass tube and the compounds dissolved in DMSO were added to the wells respectively. These plates were then incubated at 30 °C for 18 h. Inhibition of QS in C. violaceum is manifested as the inhibition of purple pigmentation around the wells containing the compounds

4. Conclusions

In conclusion, we found five new altertoxins with QS inhibitory activities against Chromobacterium violaceum CV026 from the marine-derived fungus Cladosporium sp. KFD33. These compounds represent a new type of QSIs, and can be used as lead compounds for developing new QSIs drugs, which can disarm pathogens without causing resistance of bacteria.
  11 in total

Review 1.  Quorum sensing in bacteria.

Authors:  M B Miller; B L Bassler
Journal:  Annu Rev Microbiol       Date:  2001       Impact factor: 15.500

Review 2.  Quorum sensing inhibitors as antipathogens: biotechnological applications.

Authors:  Vipin Chandra Kalia; Sanjay K S Patel; Yun Chan Kang; Jung-Kul Lee
Journal:  Biotechnol Adv       Date:  2018-11-22       Impact factor: 14.227

Review 3.  Exploiting quorum sensing to confuse bacterial pathogens.

Authors:  Breah LaSarre; Michael J Federle
Journal:  Microbiol Mol Biol Rev       Date:  2013-03       Impact factor: 11.056

4.  Metabolites with Gram-negative bacteria quorum sensing inhibitory activity from the marine animal endogenic fungus Penicillium sp. SCS-KFD08.

Authors:  Fan Dong Kong; Li Man Zhou; Qing Yun Ma; Sheng Zhuo Huang; Pei Wang; Hao Fu Dai; You Xing Zhao
Journal:  Arch Pharm Res       Date:  2016-10-05       Impact factor: 4.946

5.  Polyketides with quorum sensing inhibitory activity from the marine-derived fungus Aspergillus sp. ZF-79.

Authors:  Fei Zhang; Fan-Dong Kong; Qing-Yun Ma; Qing-Yi Xie; Li-Man Zhou; You-Xing Zhao; Lei Guo
Journal:  J Asian Nat Prod Res       Date:  2019-10-03       Impact factor: 1.569

6.  Identity and effects of quorum-sensing inhibitors produced by Penicillium species.

Authors:  Thomas Bovbjerg Rasmussen; Mette E Skindersoe; Thomas Bjarnsholt; Richard K Phipps; Kathrine Bisgaard Christensen; Peter Ostrup Jensen; Jens Bo Andersen; Birgit Koch; Thomas Ostenfeld Larsen; Morten Hentzer; Leo Eberl; Niels Hoiby; Michael Givskov
Journal:  Microbiology       Date:  2005-05       Impact factor: 2.777

7.  Characterization of Cladosporols from the Marine Algal-Derived Endophytic Fungus Cladosporium cladosporioides EN-399 and Configurational Revision of the Previously Reported Cladosporol Derivatives.

Authors:  Hong-Lei Li; Xiao-Ming Li; Attila Mándi; Sándor Antus; Xin Li; Peng Zhang; Yang Liu; Tibor Kurtán; Bin-Gui Wang
Journal:  J Org Chem       Date:  2017-09-20       Impact factor: 4.354

8.  Maniwamycins: new quorum-sensing inhibitors against Chromobacterium violaceum CV026 were isolated from Streptomyces sp. TOHO-M025.

Authors:  Atsushi Fukumoto; Chikana Murakami; Yojiro Anzai; Fumio Kato
Journal:  J Antibiot (Tokyo)       Date:  2015-12-09       Impact factor: 2.649

9.  Isoepoxydon, a new metabolite of the patulin pathway in Penicillium urticae.

Authors:  J Sekiguchi; G M Gaucher
Journal:  Biochem J       Date:  1979-08-15       Impact factor: 3.857

10.  Perylenequione Derivatives with Anticancer Activities Isolated from the Marine Sponge-Derived Fungus, Alternaria sp. SCSIO41014.

Authors:  Xiaoyan Pang; Xiuping Lin; Pei Wang; Xuefeng Zhou; Bin Yang; Junfeng Wang; Yonghong Liu
Journal:  Mar Drugs       Date:  2018-08-14       Impact factor: 5.118

View more
  5 in total

Review 1.  Untapped Potential of Marine-Associated Cladosporium Species: An Overview on Secondary Metabolites, Biotechnological Relevance, and Biological Activities.

Authors:  Gamal A Mohamed; Sabrin R M Ibrahim
Journal:  Mar Drugs       Date:  2021-11-18       Impact factor: 5.118

2.  Metabolites From the Mangrove-Derived Fungus Cladosporium sp. HNWSW-1.

Authors:  Xi Cao; Lei Guo; Caihong Cai; Fandong Kong; Jingzhe Yuan; Cuijuan Gai; Haofu Dai; Pei Wang; Wenli Mei
Journal:  Front Chem       Date:  2021-12-16       Impact factor: 5.221

Review 3.  Fungal Naphthalenones; Promising Metabolites for Drug Discovery: Structures, Biosynthesis, Sources, and Pharmacological Potential.

Authors:  Sabrin R M Ibrahim; Sana A Fadil; Haifa A Fadil; Bayan A Eshmawi; Shaimaa G A Mohamed; Gamal A Mohamed
Journal:  Toxins (Basel)       Date:  2022-02-19       Impact factor: 4.546

4.  Fungal Melanin Biosynthesis Pathway as Source for Fungal Toxins.

Authors:  Jia Gao; Max Wenderoth; Maria Doppler; Rainer Schuhmacher; Doris Marko; Reinhard Fischer
Journal:  mBio       Date:  2022-04-27       Impact factor: 7.786

Review 5.  The Genus Cladosporium: A Rich Source of Diverse and Bioactive Natural Compounds.

Authors:  Maria Michela Salvatore; Anna Andolfi; Rosario Nicoletti
Journal:  Molecules       Date:  2021-06-28       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.